5th Annual Childhood Cancer Summit Featuring NIH Director Francis Collins

On Friday, September 19, Dr. Francis Collins, the Director of the National Institutes of Health (NIH) was the keynote speaker at the 5th Annual Childhood Cancer Summit: "Pediatric Cancer: Major Advances, Major Challenges".
5th Annual Childhood Cancer Summit Featuring NIH Director Francis Collins feature image

VIDEO: Welcome to the Childhood Cancer Caucus Website

Rep. McCaul and Rep. Van Hollen: Welcome to the new website of the Congressional Childhood Cancer Caucus.
 Welcome to the Childhood Cancer Caucus Website feature image

President Signs McCaul-Butterfield 'Creating Hope Act'

Incentivizes Drug Companies to Develop New Treatments for Children with Rare Pediatric Diseases
President Signs McCaul-Butterfield 'Creating Hope Act' feature image

VIDEO: Dennis Quaid Supports the Creating Hope Act

Actor, Dennis Quaid, endorses The Creating Hope Act, which will provide market incentives for pharmaceutical companies to develop childhood cancer and other rare pediatric disease drugs.
 Dennis Quaid Supports the Creating Hope Act feature image

Latest News

Caucus Applauds NCI for Naming Pediatric Oncologist to Council of Research Advocates

Sep 30, 2014 Press Release

The Childhood Cancer Caucus applauds Dr. Harold Varmus, the Director of the National Cancer Institute (NCI), for announcing the appointment of Dr. Greg Aune, a pediatric hematologist-oncologist from The University of Texas Health Science Center at San Antonio, to NCI's Council of Research Advocates.

NCI Announces a Pediatric MATCH Trial for Childhood Cancer

Sep 19, 2014 Press Release

On September 19, Dr. Francis Collins, the Director of the National Institutes of Health (NIH), announced a new pediatric trial for children with cancer. Sponsored by the National Cancer Institute (NCI), the Molecular Analysis for Therapy Choice Program (MATCH) trial will enroll children with advanced cancers that have progressed on standard therapy.

You're Invited to the 5th Annual Childhood Cancer Summit!

Sep 4, 2014 Press Release

On Friday, September 19, the Childhood Cancer Caucus will host its 5th Annual Childhood Cancer Summit: "Pediatric Cancer: Major Advances, Major Challenges".

Concerns about Daunorubicin Shortage

Nov 12, 2013 Press Release

Representatives McCaul and Van Hollen send letters to the FDA and Teva Pharmacueticals to seek more information about the ongoing shortage of daunorubicin, an essential therapy in the treatment of leukemia in children.

5th Annual Childhood Cancer Summit Photos and Video